Skip to main content
. 2017 Oct 18;14(6):7833–7841. doi: 10.3892/ol.2017.7210

Figure 4.

Figure 4.

Antitumor activity of ADM-loaded nanoparticles in vitro. (A) Mice were inoculated subcutaneously with H22 cells (1×106/mouse/0.2 ml). (B) Xenograft tumors were harvested and presented. (C) Tumor growth curves of various treatment groups were based on the tumor volume. Data are expressed as the mean ± standard deviation (n=5). (D) Histopathology of the tumor tissues of the tumor-bearing mice (×40). ADM, Adriamycin; LMCC, lactose myristoyl carboxymethyl chitosan; AMCC, algal polysaccharide myristoyl carboxymethyl chitosan.